Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.molcel.2016.02.019

http://scihub22266oqcxt.onion/10.1016/j.molcel.2016.02.019
suck pdf from google scholar
C4806554!4806554 !26942674
unlimited free pdf from europmc26942674
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid26942674
      Mol+Cell 2016 ; 61 (5 ): 695-704
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Mitochondria-Judges and Executioners of Cell Death Sentences #MMPMID26942674
  • Bhola PD ; Letai A
  • Mol Cell 2016[Mar]; 61 (5 ): 695-704 PMID26942674 show ga
  • Apoptosis is a form of programmed cell death that is critical for basic human development and physiology. One of the more important surprises in cell biology in the last two decades is the extent to which mitochondria represent a physical point of convergence for many apoptosis-inducing signals in mammalian cells. Mitochondria not only adjudicate the decision of whether or not to commit to cell death, but also release toxic proteins culminating in widespread proteolysis, nucleolysis, and cell engulfment. Interactions among BCL-2 family proteins at the mitochondrial outer membrane control the release of these toxic proteins and, by extension, control cellular commitment to apoptosis. This pathway is particularly relevant to cancer treatment, as most cancer chemotherapies trigger mitochondrial-mediated apoptosis. In this Review, we discuss recent advances in the BCL-2 family interactions, their control by upstream factors, and how the mitochondria itself alters these interactions. We also highlight recent clinical insights into mitochondrial-mediated apoptosis and novel cancer therapies that exploit this pathway.
  • |*Apoptosis/drug effects [MESH]
  • |*Signal Transduction/drug effects [MESH]
  • |Animals [MESH]
  • |Antineoplastic Agents/therapeutic use [MESH]
  • |Apoptosis Regulatory Proteins/*metabolism [MESH]
  • |Humans [MESH]
  • |Mitochondria/drug effects/*metabolism/*pathology [MESH]
  • |Mitochondrial Membrane Transport Proteins/metabolism [MESH]
  • |Mitochondrial Membranes/metabolism [MESH]
  • |Mitochondrial Permeability Transition Pore [MESH]
  • |Molecular Targeted Therapy [MESH]
  • |Neoplasms/drug therapy/metabolism/pathology [MESH]
  • |Permeability [MESH]
  • |Protein Binding [MESH]
  • |Protein Interaction Domains and Motifs [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box